On evaluating recombinant Mdh1 protein as an antigenic candidate for a vaccine against candidiasis, Shibasaki et al. found that both subcutaneous and intradermal administration of recombinant Mdh1 protein induced significantly higher antibody responses and elicited significant protection against C. albicans mediated systemic infection in mice [288]. The gene discussed is MDH1; the disease is candidiasis.